SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bafna Pharmaceuticals allots equity shares

18 Sep 2012 Evaluate
Bafna Pharmaceuticals has informed that the board of directors of the company at its meeting held on September 15, 2012, has allotted 1,50,000 equity shares pursuant to conversion of warrants into equity shares after receipt of 75% of balance money, warrants allotted on March 17, 2011.

Further, cancelled 20,43,000 convertible warrants allotted on March 17, 2011 for non payment of balance money within 18 months and forfeited the 25% (application) money paid at the time of allotment of warrants. The paid-up share capital of the company increased to Rs. 18,65,63,350 comprising of 1,86,56,335 equity shares of Rs 10 each.

The above information is a part of company's filings submitted to BSE.

Bafna Pharma Share Price

137.90 -7.10 (-4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×